3591 - 3600 of 6295 Results
Title
Year
-
OPENTitle: Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT imagesJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 16Issue #:Start Page: 539End Page: 544Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nicl.2017.08.021Best OA location URL: https://doi.org/10.1016/j.nicl.2017.08.021Citation Count: 98
-
OPENTitle: Studying the Parkinson’s disease metabolome and exposome in biological samples through different analytical and cheminformatics approaches: a pilot studyJournal Name: Analytical and Bioanalytical ChemistryPublisher: Springer Science and Business Media LLCVol: 414Issue #: 25Start Page: 7399End Page: 7419Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00216-022-04207-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s00216-022-04207-z.pdfCitation Count: 28
-
OPENTitle: Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelJournal Name: Nature NeurosciencePublisher: Springer Science and Business Media LLCVol: 25Issue #: 2Start Page: 213End Page: 225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41593-021-00999-yBest OA location URL: https://escholarship.org/uc/item/9gr017hqCitation Count: 423
-
OPENTitle: Sensitive ELISA-based detection method for the mitophagy marker p-S65-Ub in human cells, autopsy brain, and blood samplesJournal Name: AutophagyPublisher: Informa UK LimitedVol: 17Issue #: 9Start Page: 2613End Page: 2628Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1080/15548627.2020.1834712Best OA location URL: https://doi.org/10.1080/15548627.2020.1834712Citation Count: 55
- Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteins2018OPENTitle: Active site alanine mutations convert deubiquitinases into high‐affinity ubiquitin‐binding proteinsJournal Name: EMBO reportsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.15252/embr.201745680Best OA location URL: https://doi.org/10.15252/embr.201745680Citation Count: 55
-
OPENTitle: The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12883-024-03914-7Best OA location URL: https://doi.org/10.1186/s12883-024-03914-7Citation Count: 1
-
OPENTitle: Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer's disease and progressive supranuclear palsyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.14249Best OA location URL: https://doi.org/10.1002/alz.14249Citation Count: 11
-
OPENTitle: RTP801 mediates transneuronal toxicity in culture via extracellular vesiclesJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 12Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jev2.12378Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12378Citation Count: 6
-
OPENTitle: In Silico Labeling: Predicting Fluorescent Labels in Unlabeled ImagesJournal Name: CellPublisher: Elsevier BVVol: 173Issue #: 3Start Page: 792End Page: 803.e19Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.cell.2018.03.040Best OA location URL: http://www.cell.com/article/S0092867418303647/pdfCitation Count: 609
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Citation Count: 14